Business

Indicative Announcement on Reply to Letter of Review and Inquiry on Application Documents for Public Issuance of Convertible Corporate Bonds (Revised Edition)

Indicative Announcement on Reply to Letter of Review and Inquiry on Application Documents for Public Issuance of Convertible Corporate Bonds (Revised Edition)

articleNanjing Well Pharmaceutical Group Co. Ltd. Class ANovember 3, 20234/news/indicative-announcement-on-reply-to-letter-of-review-and-inquiry-on-application-documents-for-public-issuance-of-convertible-corporate-bonds-revised-edition
Indicative Announcement on Reply to Letter of Review and Inquiry on Application Documents for Public Issuance of Convertible Corporate Bonds (Revised Edition)

About this update from Nanjing Well Pharmaceutical Group Co. Ltd. Class A

Indicative Announcement on Reply to Letter of Review and Inquiry on Application Documents for Public Issuance of Convertible Corporate Bonds (Revised Edition)The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:" target="_blank">View Attachment

View stock analysis, news, and events for Nanjing Well Pharmaceutical Group Co. Ltd. Class A